There is a possibility of Indian cos becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).Exclusive: Gilead says open to collaborate with govts, drug cos to make Remdesivir globally available
There is a possibility of Indian cos becoming part of the consortium, in the past Gilead used voluntary licenses to rope in Indian cos to manufacture and launch HIV and hepatitis-C medications in low-middle-income countries (LMICs).
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment